Insempra
PrivateLast Round
Series A
May 7, 2024
Total Funding Raised
$35M
Company Overview
Insempra operates in Healthcare & Life Sciences and is based in Planegg. Its latest recorded funding round was a Series A round in May 2024.
Insempra is a biotechnology company that develops sustainable, bio-based ingredients for the beauty, nutrition, and fashion industries by leveraging synthetic biology and precision fermentation to reduce reliance on petrochemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insempra Comparables
Compare Insempra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lantana Bio | 83% | |
| Debut | 83% | |
| LipoTrue | 81% |
For institutional investors. Book with your work email.
Insempra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2024 | ||||
| Seed | May 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Insempra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alante Capital | Series A |
| EQT Ventures | Seed, Series A |
| BlueYard Capital | Series A, Seed |
| Acequia Capital | Seed, Series A |
| Taavet+Sten | Series A |
| Possible Ventures | Seed, Series A |
| Bayern Kapital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Giovanni Salerno appointed as the new Chief Commercial Officer.
- Apr 8, 2025
Introduced Superior PEA at the in-cosmetics Global event in Amsterdam.
For institutional investors. Book with your work email.
Insempra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Insempra's valuation, stock price, and market status.
Is Insempra a public or private company?
Insempra is a private company.
What is the current stock price of Insempra?
Insempra is a private company, so its shares have no public market price. Caplight tracks Insempra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Insempra worth (valuation)?
Valuation information for Insempra is not publicly available.
Can I buy Insempra stock?
Insempra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Insempra's last funding round?
Insempra's most recent funding round was Series A on May 7, 2024.
Who are the main investors in Insempra?
Key investors in Insempra include EQT Ventures, EQT Ventures.
Will Insempra IPO soon?
No public IPO plans have been announced for Insempra.
How can I track Insempra secondary market activity?
Caplight tracks bids, offers, and trades in Insempra's shares on secondary markets.